difference between semaglutide & tirzepatide vs Tirzepatide: Compare Diabetes Medications Semaglutide vs. Tirzepatide: Which GLP-1

Description

Patients who stop before 12 months typically achieve less total weight loss and experience faster regain than those who continue longer

Injection site reactions, including erythema, pruritus, and nodule formation (particularly with extended-release formulations), occur in approximately 10-20% of patients

Zepbound is contraindicated in patients with a personal or family history of medullary thyroid carcinoma, in patients with Multiple Endocrine Neoplasia syndrome type 2, and in patients with known serious hypersensitivity to tirzepatide or any of the excipients in Zepbound

Decrease hunger Decrease food intake

[19] [20] The rate and magnitude of glycemic deterioration depend on individual factors including baseline diabetes severity, duration of disease, beta-cell function, and lifestyle factors